What does CUSIP 74365A309 represent in this 13F holders report?

CUSIP 74365A309 is the security identifier for PLX - Protalix BioTherapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PLX - Protalix BioTherapeutics, Inc. - Common Stock in Q1 2023?

34 institutional investors reported PLX - Protalix BioTherapeutics, Inc. - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

Protalix BioTherapeutics, Inc. - Common Stock (PLX)

CUSIP: 74365A309

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock
Total 13F shares: 2,937,638
Total 13F value: $6,146,705
Share change: -630,184
Put/Call ratio: 20%
SEC-reported price per share: $2.10
Number of holders: 34
Value change: +$447,739
Number of buys: 18
Number of sells: 10
Shares outstanding: 80,610,558

Security key

74365A309

Report period

Q1 2023

Institutions

Top holders

PLX full security history Ownership snapshot Full 13F holder table Protalix BioTherapeutics, Inc. SEC filings Protalix BioTherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PLX - Protalix BioTherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

HIGHBRIDGE CAPITAL MANAGE...

Disclosed value leader

HIGHBRIDGE CAPITAL MANAGE...

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 3% Showing 1-6 of 15 holder rows.

Quick read

HIGHBRIDGE CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HIGHBRIDGE CAPITAL MANAGEMENT LLC's linked filing trail.

Comparable ownership Top 5

HIGHBRIDGE CAPITAL MANAGEMENT LLC 3%

MEITAV INVESTMENT HOUSE LTD 0.3%

RENAISSANCE TECHNOLOGIES LLC 0.28%

BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.17%

CITADEL ADVISORS LLC 0.15%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F Company 13F	3%	$3,306,000 2,413,487 shares	—	31 Dec 2022
MEITAV INVESTMENT HOUSE LTD	13F Company 13F	0.3%	$318,828 244,482 shares	—	31 Dec 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.28%	$308,000 224,603 shares	—	31 Dec 2022
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F Company 13F	0.17%	$183,292 133,790 shares	—	31 Dec 2022
CITADEL ADVISORS LLC	13F Company 13F	0.15%	$170,301 124,307 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	0.13%	$139,594 101,893 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,937,638

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %